Friedman-Kien A E, Eron L J, Conant M, Growdon W, Badiak H, Bradstreet P W, Fedorczyk D, Trout J R, Plasse T F
Department of Dermatology, New York University Medical Center 10016.
JAMA. 1988;259(4):533-8.
The activity of natural (leukocyte) interferon alfa in the treatment of condylomata acuminata was assessed in a randomized, double-blind, placebo-controlled, multicenter trial. Interferon alfa (Alferon N Injection) or placebo was injected into lesions twice weekly for up to eight weeks. Eighty-six patients were given interferon alfa, and 72 were given placebo. Eighty-six percent of interferon alfa-treated patients and 89% of placebo-treated patients had received previous therapy for condylomata acuminata. Side effects, usually flulike symptoms, occurred briefly after the injections; if present, they disappeared before the end of the third week of therapy. Treatment completely eliminated warts in 62% of interferon alfa-treated patients compared with only 21% of placebo-treated patients. Natural interferon alfa given intralesionally is an effective and safe treatment even in patients with recurrent or recalcitrant genital warts.
在一项随机、双盲、安慰剂对照、多中心试验中评估了天然(白细胞)干扰素α治疗尖锐湿疣的活性。将干扰素α(Alferon N注射剂)或安慰剂每周两次注射到病灶中,持续长达八周。86例患者接受干扰素α治疗,72例患者接受安慰剂治疗。接受干扰素α治疗的患者中有86%和接受安慰剂治疗的患者中有89%曾接受过尖锐湿疣的先前治疗。副作用通常为流感样症状,注射后短暂出现;如果出现,它们在治疗第三周结束前消失。62%接受干扰素α治疗的患者疣完全消除,而接受安慰剂治疗的患者中只有21%。即使对于复发性或顽固性生殖器疣患者,病灶内注射天然干扰素α也是一种有效且安全的治疗方法。